{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-035959","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2026-05-18T20:30:33+00:00","discovered_at":"2026-05-18T20:32:00.292894+00:00","generated_at":"2026-05-18T20:32:22.238334+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Medtronic neuroscience president Brett Wall to depart; Kweli Thompson named successor","bullets":["Brett Wall steps down as EVP & President, Neuroscience Portfolio; effective June 1, 2026.","Dr. Kweli Thompson moves from SVP & President, Cardiac Rhythm Management to succeed him.","Wall will remain an employee through September 1, 2026 to assist transition.","Severance consistent with Medtronic's executive severance practices per 2025 proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-035959","json":"https://secwatch.observer/filing/0001628280-26-035959.json","markdown":"https://secwatch.observer/filing/0001628280-26-035959.md","text":"https://secwatch.observer/filing/0001628280-26-035959.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/0001628280-26-035959-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/mdt-20260518.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T20:32:22.238334+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09c2021e90","claim":"Brett Wall departed as Executive Vice President and President, Neuroscience Portfolio at Medtronic plc.","evidence_excerpt":"Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/0001628280-26-035959-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departing"},{"label":"Role","value":"Executive Vice President and President, Neuroscience Portfolio"}],"fact_type":"executive_change"},{"claim_id":"d567fb7b38","claim":"Kweli Thompson changed role as Executive Vice President and President, Neuroscience Portfolio at Medtronic plc.","evidence_excerpt":"Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/0001628280-26-035959-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"assuming the role"},{"label":"Role","value":"Executive Vice President and President, Neuroscience Portfolio"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}